Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future by Aileen O'Gorman, Eberhard Schatz

Connect to this object online.

Harm reduction in Europe: a framework for civil society-led monitoring by Rafaela Rigoni, Tuukka Tammi, Daan van der Gouwe, Eberhard Schatz

Connect to this object online.

Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European... by Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz, Jeffrey V. Lazarus

Connect to this object online.

Hepatitis C services at harm reduction centres in the European Union: a 28-country survey by Juan M. Pericàs, Daniel J. Bromberg, Denise Ocampo, Eberhard Schatz, Iwona Wawer, Piotr Wysocki, Kelly Safreed-Harmon, Jeffrey V. Lazarus

Connect to this object online.

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA. by Katherine C Sharrock, Teymur Noori, Maria Axelsson, Maria Buti, Asuncion Diaz, Olga Fursa, Greet Hendrickx, Cary James, Irena Klavs, Marko Korenjak, Mojca Maticic, Antons Mozalevskis, Lars Peters, Rafaela Rigoni, Magdalena Rosinska, Kristi Ruutel, Eberhard Schatz, Thomas Seyler, Irene Veldhuijzen, Erika Duffell

Connect to this object online.

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA by Katherine C. Sharrock, Teymur Noori, Maria Axelsson, Maria Buti, Asuncion Diaz, Olga Fursa, Greet Hendrickx, Cary James, Irena Klavs, Marko Korenjak, Mojca Maticic, Antons Mozalevskis, Lars Peters, Rafaela Rigoni, Magdalena Rosinska, Kristi Ruutel, Eberhard Schatz, Thomas Seyler, Irene Veldhuijzen, Erika Duffell

Connect to this object online.